Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 062739
Company: LILLY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TAZIDIME IN PLASTIC CONTAINER CEFTAZIDIME 1GM/VIAL INJECTABLE;INJECTION Discontinued None No No
TAZIDIME IN PLASTIC CONTAINER CEFTAZIDIME 2GM/VIAL INJECTABLE;INJECTION Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/10/1986 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/15/1996 SUPPL-10 Labeling

Label is not available on this site.

02/26/1996 SUPPL-9 Labeling

Label is not available on this site.

10/18/1993 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

04/02/1993 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

12/07/2007 SUPPL-6 Labeling

Label is not available on this site.

02/14/1992 SUPPL-5 Labeling

Label is not available on this site.

02/14/1992 SUPPL-4 Labeling

Label is not available on this site.

10/30/1986 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

01/23/1987 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

09/09/1986 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English